PHVS
Pharvaris N.V. - Ordinary Shares (PHVS)
$02
About Pharvaris N.V. - Ordinary Shares (PHVS)
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
Details
Daily high
$36.88
Daily low
$35.50
Price at open
$36.33
52 Week High
$43.25
52 Week Low
$20.65
Market cap
2.5B
Dividend yield
-
Volume
653,735
Avg. volume
1.1M
P/E ratio
-11.92
Pharvaris N.V. - Ordinary Shares News
Details
Daily high
$36.88
Daily low
$35.50
Price at open
$36.33
52 Week High
$43.25
52 Week Low
$20.65
Market cap
2.5B
Dividend yield
-
Volume
653,735
Avg. volume
1.1M
P/E ratio
-11.92